Latest News and Press Releases

DURHAM, N.C., June 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today reported on the results of two University of Miami Miller School of Medicine studies involving the...

DURHAM, N.C., May 19, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced today that the Company has formalized working relationships with an international cosmetic company...

DURHAM, N.C., May 18, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced it has hired Jim Weiss to the newly created position of Sales Director.  In this...

DURHAM, N.C., May 17, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced that the company will not present at the Rodman & Renshaw Global Investment Conference today as...

DURHAM, N.C., May 12, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company will present at the Rodman & Renshaw Global Investment Conference on Monday,...

DURHAM, N.C., May 4, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc., a Delaware corporation (Nasdaq:OXBT) (the "Company"), announced today that it entered into purchase agreements with certain...

DURHAM, N.C., April 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company will present at the BIO International Convention at McCormick Place in...

DURHAM, N.C., April 22, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company has begun shipping its newly formulated Dermacyte™ Oxygen Concentrate...

DURHAM, N.C., April 13, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the presentation made by Chairman and CEO Chris Stern at the Swiss Equity Biotech...

DURHAM, N.C., April 7, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that its Chairman and CEO Chris Stern will present at the Swiss Equity Biotech Conference at...